Sai Life Sciences Begins Commercial Ops at Expanded Bidar Plant.

Sai Life Sciences Limited announced the successful commencement of commercial operations for the second and final phase of its production block at its Bidar facility (Unit IV) on June 19, 2025. This expansion adds approximately 91 kL of capacity, completing a significant overall addition of roughly 195 kL that was previously under construction.

With this latest phase now operational, the combined capacity of the Unit IV Bidar Facility reaches approximately 640 kL. This enhanced capacity will enable Sai Life Sciences to supply Registered Starting Materials (RSM), intermediates, and Active Pharmaceutical Ingredients (APIs) for both clinical and commercial applications, further strengthening its capabilities in the pharmaceutical sector.